Relationship of leukocyte CR1 transcript and protein with the pathophysiology and prognosis of systemic lupus erythematosus: A follow-up study

Lupus

Volumn 20, Issue 10, 2011, Pages 1010-1018

  Arora, V ^a   Grover, R ^b   Kumar, A ^b   Anand, D ^c   Das, N ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b FORTIS HOSPITAL   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

complement receptor 1; follow up; SLE disease activity index; systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; COMPLEMENT COMPONENT C3B RECEPTOR; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; PREDNISOLONE;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CORRELATIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; GENETIC TRANSCRIPTION; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROGNOSIS; RECEPTORS, COMPLEMENT 3B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

EID: 80052901052     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311400112     Document Type: Article

References (32)

1. Bao L, Quigg RJ. Complement in lupus nephritis: the good, the bad, and the unknown. Semin Nephrol. 2007 ; 27: 69-80
2. Chen M, Daha MR, Kallenberg CG. The complement system in systemic autoimmune disease. J Autoimmun. 2010 ; 34: 276-286
3. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol. 2004 ; 22: 431-456 (Pubitemid 38680429)
4. Tsao BP. An update on genetic studies of systemic lupus erythematosus. Curr Rheumatol Rep. 2002 ; 4: 359-367
5. Khera R, Das N. Complement Receptor 1: Disease associations and therapeutic implications. Molecular Immunology. 2009 ; 46: 761-772
6. Gasque P, Morgan BP. Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes. Immunology. 1996 ; 89: 338-347 (Pubitemid 26380073)
7. Marzocchi-Machado CM, Alves CM, Azzolini AE, Polizello AC, Carvalho IF, Lucisano-Valim YM. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum. J Autoimmun. 2005 ; 25: 289-97 (Pubitemid 41642975)
8. Wilson JG, Ratnoff WD, Schur PH, Fearon DT. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B-lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum. 1986 ; 29: 739-747 (Pubitemid 16094151)
9. Arora M, Arora R, Tiwari SC, Das N, Srivastava LM. Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis. Lupus. 2000 ; 9: 127-131 (Pubitemid 30171110)
10. Ross GD, Walport MJ, Mackworth-Young C, Watson JV, Hogg N, Lachmann PJ. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol. 1985 ; 59: 547-554 (Pubitemid 15127603)
11. Wilson JG, Wong WW, Murphy EE, Schur PH, Fearon DT. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene. J Immunol. 1987 ; 138: 2708-2710
12. Iida K, Mornaghi R, Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med. 1982 ; 155: 1427-1438 (Pubitemid 12102088)
13. Holme E, Fyfe A, Zoma A, Veitch J, Hunter J, Whaley K. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. Clin Exp Immunol. 1986 ; 63: 41-48 (Pubitemid 16196399)
14. Marquart HV, Svendsen A, Rasmussen JM, et al. Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol. 1995 ; 101: 60-65
15. Sivasankar B, Dinda AK, Tiwari SC, Srivastava LM, Das N. Modulation of urinary CR1 in systemic lupus erythematosus. Lupus. 2004 ; 13: 228-233 (Pubitemid 38649621)
16. Verma J, Arora V, Marwaha V, Kumar A, Das N. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus. Lupus. 2005 ; 14: 273-279 (Pubitemid 40559172)
17. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277 (Pubitemid 13221242)
18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
19. Arora V, Verma J, Dutta R, Marwah V, Kumar A, Das N. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus. Mol Immunol. 2004 ; 41: 449-456 (Pubitemid 38639896)
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 ; 162: 156-159 (Pubitemid 17064313)
21. Kumar A. Indian guidelines on the management of SLE. J Indian Rheumatol Assoc. 2002 ; 10: 80-96
22. Thomsen BS, Nielsen H, Andersen V. Erythrocyte CR1 (C3b/C4b receptor) levels and disease activity in patients with SLE. Scand J Rheumatol. 1987 ; 16: 339-346 (Pubitemid 17164431)
23. de Carvalho Lins CE, Pereira Crott LS, Teixeira JE, Barbosa JE. Reduced erythrocyte complement receptor type 1 in systemic lupus erythematosus is related to a disease activity index and not to the presence or severity of renal disease. Lupus. 2004 ; 13: 517-521 (Pubitemid 39071205)
24. Kumar A, Malaviya AN, Sinha S, Khandekar PS, Banerjee K, Srivastava LM. C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis. Low receptor levels on erythrocytes are an acquired phenomenon. Immunol Res. 1994 ; 13: 61-71
25. Yoshida K, Yukiyama Y, Hirose S, Miyamoto T. The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus. Clin Exp Immunol. 1985 ; 60: 613-621 (Pubitemid 15021366)
26. Urquizu-Padilla M, Balada E, Cortés F, Pérez EH, Vilardell-Tarrés M, Ordi-Ros J. Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus. J Rheumatol. 2009 ; 36: 953-960
27. Birmingham DJ, Gavit KF, McCarty SM, Yu CY, Rovin BH, Nagaraja HN, Hebert LA. Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare. Clin Exp Immunol. 2006 ; 143: 274-280
28. Hebert LA. Clearance of immune-complexes from the circulation of man and other primates. Am J Kidney Dis. 1991 ; 17: 352-352
29. Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol. 2009 ; 9: 729-740
30. Erdei A, Isaák A, Török K, Kremlitzka M, Prechl J, Bajtay Z. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions. Mol Immunol. 2009 ; 46: 2767-2773
31. Carroll MC. The complement system in regulation of adaptive immunity. Nature Immunol. 2004 ; 5: 981-986 (Pubitemid 41057714)
32. Pascual M, Duchosal MA, Steiger G, et al. Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes. J Immunol. 1993 ; 151: 1702-1711 (Pubitemid 23219309)